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Abstract
Background: High mammographic density might mask breast tumors, resulting in delayed diagnosis or missed cancers.
Purpose: To investigate the association between mammographic density and histopathologic tumor characteristics
(histologic type, size, grade, and lymph node status) among women screened in the Norwegian Breast Cancer
Screening Program.
Material and Methods: Information about 1760 screen-detected ductal carcinoma in situ (DCIS) and 7366 invasive
breast cancers diagnosed among women aged 50–69 years, 1996–2010, was analyzed. The screening mammograms were
classified subjectively according to the amount of fibroglandular tissue into fatty, medium dense, and dense by breast
radiologists. Chi-square test was used to compare the distribution of tumor characteristics by mammographic density.
Odds ratio (OR) of tumor characteristics by density was estimated by means of logistic regression, adjusting for
screening mode (screen-film and full-field digital mammography), and age.
Results: Mean and median tumor size of invasive breast cancers was 13.8 and 12 mm, respectively, for women with fatty
breasts, and 16.2 and 14 mm for those with dense breasts. Lymph node positive tumors were identified among 20.6% of
women with fatty breasts compared with 27.2% of those with dense breasts (P< 0.001). The proportion of DCIS was
significantly lower for women with fatty (15.8%) compared with dense breasts (22.0%). Women with dense breasts had
an increased risk of large (OR, 1.44; 95% CI, 1.18–1.73) and lymph node positive tumors (OR, 1.26; 95% CI, 1.05–1.51)
compared with women with fatty and medium dense breasts.
Conclusion: High mammographic density was positively associated with tumor size and lymph node positive tumors.
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Introduction
High mammographic density is known to mask breast
tumors, leading to delayed diagnosis and reducing the
eﬀectiveness of mammographic screening (1,2). Tumors
masked by high mammographic density are often char-
acterized by a less favorable prognosis (3–7). This is
reﬂected by larger tumor size (3–7), higher histologic
grade (6), and lymph node involvement (4,5,7).
However, a recent study reported that very low density
predicted poorer outcome in women with invasive
breast cancer (8). To better understand potential
impact of mammographic density on prognosis
among women participating in the Norwegian Breast
Cancer Screening Program (NBCSP), we investigated
the association between mammographic density and
histopathologic characteristics of screen-detected
tumors.
Material and Methods
The NBCSP is a population-based program inviting
women aged 50–69 years to two-view mammography
every second year. About 75% of the invited women
participate. The program is administered by the Cancer
Registry of Norway (9). A nationwide screening
database contains information about all screening and
recall examinations. This study was approved by
the Regional Committee for Medical and Health
Research Ethics.
In this case-only study, we included information
about 1760 screen-detected ductal carcinoma in situ
(DCIS) and 7366 invasive breast cancers diagnosed
among women aged 50–69 years at diagnosis in the
period 1996–2010. Mammographic density was subject-
ively classiﬁed according to the percentage of ﬁbro-
glandular tissue on the screening mammogram as
fatty (<30% of ﬁbroglandular tissue), medium dense
(30–70% of ﬁbroglandular tissue), and dense (>70%
of ﬁbroglandular tissue) by the trained breast radiolo-
gists who performed the diagnostic workup. To start
working as breast radiologists in the NBCSP, radiolo-
gists have to undergo special training (10). In addition,
to continue reading mammograms in the program,
breast radiologists are recommended to read a min-
imum of 5000 screening examinations annually and to
conduct diagnostic mammography (10).
Chi-square test was used to compare the distribution
of histologic type (DCIS, invasive ductal carcinoma
[IDC], invasive lobular carcinoma [ILC], and other
invasive cancers) and to compare the distribution of
tumor size (15mm vs. >15mm), histologic grade (I
vs. II and III), and lymph node status (positive or nega-
tive) of invasive cancers between fatty and medium
dense breasts and between fatty and dense breasts.
DCIS was included in analyses solely to study the
distribution of histologic type. The distribution of
tumor size, histologic grade, and lymph node status
by mammographic density categories was studied for
invasive cancers only. We used logistic regression to
estimate the odds ratio (OR) of tumor characteristics
of invasive cancers associated with mammographic
density categories. Information about DCIS was not
included in regression analysis. Tumor characteristics
were the outcome variables. For regression analyses,
mammographic density was dichotomized into fatty
and medium dense versus dense. We adjusted for age
groups (50–54, 55–59, 60–64, and 65–69 years) and
screening mode, deﬁned as screen-ﬁlm mammography
(SFM) and full-ﬁeld digital mammography (FFDM). A
total of 5170 invasive breast cancers were diagnosed
using SFM, while 2196 were diagnosed with FFDM.
All tests were two-sided with a 5% signiﬁcance level.
Statistical analyses were conducted using STATA
software, Version 13.0 (StataMP, StataCorp; College
Station, TX, USA).
Results
Mean and median tumor size of invasive breast cancers
was 13.8mm (95% conﬁdence interval [CI], 13.4–14.1)
and 12mm, respectively, for women with fatty breasts
(Table 1). The values were 16.2mm (95% CI, 15.4–
17.0) and 14mm for women with dense breasts. The
percentage of tumors >15mm was 28.1% among
women with fatty breasts and 37.6% among those
with dense breasts (P< 0.001). There were no statistic-
ally signiﬁcant diﬀerences in histologic grade by mam-
mographic density. Lymph node positive tumors were
less common in women with fatty breasts (20.6%) com-
pared with women with dense breasts (27.2%).
Compared with women with fatty and medium dense
breasts, women with dense breasts had an OR of large
tumors of 1.44 (95% CI, 1.18–1.73) and an OR of
lymph node positive tumors of 1.26 (95% CI, 1.05–
1.51) in adjusted analyses. Including screening mode
in the model did not change the estimates (data not
shown). DCIS represented 15.8% and 22.0% of the
cancers among women with fatty and dense breasts
(P< 0.001), respectively, while the proportions of ILC
were 6.8% and 11.1%, respectively (P< 0.001).
Discussion
Our study identiﬁed an association between mammo-
graphic density, tumor size, and lymph node status.
The results support the ﬁndings from other
studies, where various methods were used to classify
density (3–7).
Several studies have reported a larger tumor size in
dense compared with fatty breasts (3–7). The larger
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tumor size is associated with masking, which is also
related to missed tumors, and thus missed tumors of
large size (3,4). Masking decreases the sensitivity of
screening programs (1,2). Stratifying women for
breast cancer screening by mammographic density
and consequently oﬀering additional screening tools
for those with dense breasts might be beneﬁcial for
those with dense breasts (1,2).
We did not identify any association between mam-
mographic density and histologic grade of the screen-
detected tumors. Similar results were reported in a
recent study from Sweden (7). However, other studies
have reported mammographic density to be either posi-
tively (6) or negatively (4,8) associated with histologic
grade. A positive association between mammographic
density and grade was assumed to reﬂect a biological
relationship between a high amount of breast glandular
tissue and a low degree of tumor diﬀerentiation (or high
histologic grade) (6). A negative association between
mammographic density and histopathologic grade was
suggested to be related to the tissue microenvironment
in fatty breasts, which might be more promoting
towards high-grade tumors (7).
Our ﬁndings are in contrast with the results from a
recent study by Masarwah et al., which reported
unfavorable prognostic outcomes among women with
very low density when compared with those with mixed
or low density (8). The study by Masarwah et al.
included a relatively small number of women
(n¼ 270) aged 32–86 years, who were diagnosed with
symptomatic breast cancer (8). The results are thus con-
sidered not comparable.
This registry-based study included a large number of
screen-detected breast cancers with high completeness
of data on histopathologic tumor characteristics (less
than 5% missing). A limitation of the study is lack of
information about body mass index, use of hormonal
therapy, and other breast cancer risk factors that could
have confounded the association between mammo-
graphic density and the outcome variables (11).
Another limitation of the study is the subjective three-
category classiﬁcation of mammographic density used
in the NBCSP. This classiﬁcation is diﬀerent from the
commonly used BI-RADS (12). In addition, mammo-
graphic density was classiﬁed solely in the women
recalled for further assessment due to abnormal
Table 1. Histopathologic characteristics of screen-detected breast cancers in the Norwegian Breast Cancer Screening Program,
1996–2010, by mammographic density (fatty, medium dense, and dense breasts).
Fatty n (%) Medium dense n (%) P value* Dense n (%) P valuey Total n (%)
Histologic type n¼ 2721 n¼ 5538 n¼ 867 n¼ 9126
Ductal carcinoma in situ 429 (15.8) 1140 (20.6) <0.001 191 (22.0) <0.001 1760 (19.3)
Invasive ductal carcinoma 1959 (72.0) 3660 (66.1) <0.001 557 (64.2) <0.001 6176 (67.7)
Invasive lobular carcinoma 184 (6.8) 475 (8.6) 0.004 96 (11.1) <0.001 755 (8.3)
Other invasive cancers 149 (5.5) 263 (4.8) 0.154 23 (2.7) 0.001 435 (4.8)
Invasive breast cancers n¼ 2292 n¼ 4398 n¼ 676 n¼ 7366
Tumor size
Mean, mm 13.8 14.7 16.2 14.5
(95% CI) (13.4–14.1) (14.4–14.9) <0.001 (15.4–17.0) <0.001 (14.3–14.7)
Median (mm) 12 13 14 13
15 mm 1601 (69.9) 2834 (64.4) <0.001 386 (57.1) <0.001 4821 (65.5)
>15 mm 645 (28.1) 1443 (32.8) <0.001 254 (37.6) <0.001 2342 (31.8)
Missing information 46 (2.0) 121 (2.8) 0.064 36 (5.3) <0.001 203 (2.7)
Histologic grade
Grade I 770 (33.6) 1532 (34.8) 0.311 235 (34.7) 0.573 2537 (34.4)
Grade II and III 1472 (64.2) 2751 (62.6) 0.179 425 (62.9) 0.52 4648 (63.1)
Missing information 50 (2.2) 115 (2.6) 0.278 16 (2.4) 0.774 181 (2.5)
Lymph nodes
Negative 1740 (75.9) 3150 (71.6) <0.001 453 (67.0) <0.001 5343 (72.5)
Positive 472 (20.6) 1097 (24.9) <0.001 184 (27.2) <0.001 1753 (23.8)
Missing information 80 (3.5) 151 (3.4) 0.904 39 (5.8) 0.008 270 (3.7)
*For comparison of fatty and medium dense breasts.
yFor comparison of fatty and dense breasts.
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mammographic ﬁndings, non-satisfactory images or
clinical symptoms. Thus, we did not have information
about the distribution of mammographic density in the
screened population.
In conclusion, our ﬁndings indicate that high mam-
mographic density among women with screen-detected
cancers is positively associated with larger tumor size
(>15mm) and positive lymph node status. Masking by
mammographic density might result in less favorable
prognosis for the women and a decreased sensitivity
of the screening program. Stratifying women for
breast cancer screening by mammographic density is a
possible approach to reduce the described limitation of
mammography as a screening tool.
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